Callan Family Office’s Ovintiv OVV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.17M Buy
19,756
+1,756
+10% +$84.7K 0.03% 519
2025
Q4
$705K Buy
18,000
+8,888
+98% +$345K 0.02% 659
2025
Q3
$368K Sell
9,112
-4,385
-32% -$179K 0.01% 635
2025
Q2
$514K Buy
+13,497
New +$495K 0.02% 575

Other funds holding OVV

Callan Family Office's OVV Position: Q1 2026 in Review

Callan Family Office increased its Ovintiv (OVV) stake by 9.8% in Q1 2026, buying an estimated $84.7K and bringing the position to 19,756 shares worth $1.17M. The position accounts for 0.03% of the portfolio, ranked #519.

Callan Family Office first reported a position in OVV in Q2 2025 and has held it in 4 quarters since. 609 funds tracked by Wall St. Rank hold OVV as of Q1 2026.

  • Callan Family Office held 19,756 shares of Ovintiv worth $1.17M as of Q1 2026.
  • Callan Family Office bought 1,756 Ovintiv shares in Q1 2026, an estimated $84.7K.
  • Ovintiv made up 0.03% of Callan Family Office's portfolio in Q1 2026, its #519 holding.
  • Callan Family Office first reported a position in Ovintiv in Q2 2025 and has held it in 4 quarters since.
  • 609 funds tracked by Wall St. Rank held Ovintiv as of Q1 2026.

Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.